| Literature DB >> 29398668 |
Quan Feng Liu1,2, Youngjae Jeon3, Yung-Wei Sung1,2, Jang Ho Lee3, Haemin Jeong3, Young-Mi Kim4, Hye Sup Yun3, Young-Won Chin4, Songhee Jeon5,6, Kyoung Sang Cho3, Byung-Soo Koo1,2.
Abstract
The Nardostachys jatamansi DC (NJ) root has been used as a sedative or analgesic to treat neurological symptoms and pain in traditional Korean medicine. Here, we investigate the potential effects of NJ on Alzheimer's disease (AD) and reveal the molecular mechanism through which NJ exerts its effects. The neuroprotective effect of the NJ root ethanol extract against β amyloid (Aβ) toxicity was examined in vitro using a cell culture system and in vivo using a Drosophila AD model. The NJ extract and chlorogenic acid, a major component of NJ, inhibited Aβ-induced cell death in SH-SY5Y cells. Moreover, the NJ extract rescued the neurological phenotypes of the Aβ42-expressing flies (decreased survival and pupariation rate and a locomotor defect) and suppressed Aβ42-induced cell death in the brain. We also found that NJ extract intake reduced glial cell number, reactive oxygen species level, extracellular-signal-regulated kinase (ERK) phosphorylation, and nitric oxide level in Aβ42-expressing flies, without affecting Aβ accumulation. These data suggest that the neuroprotective activity of NJ might be associated with its antioxidant and anti-inflammatory properties, as well as its inhibitory action against ERK signaling; thus, NJ is a promising medicinal plant for the development of AD treatment.Entities:
Keywords: Alzheimer’s disease; Drosophila; Nardostachys jatamansi; anti-inflammation; antioxidant; extracellular-signal-regulated kinase
Mesh:
Substances:
Year: 2018 PMID: 29398668 DOI: 10.1248/bpb.b17-00750
Source DB: PubMed Journal: Biol Pharm Bull ISSN: 0918-6158 Impact factor: 2.233